Literature DB >> 8640090

Nosocomial candidemia in a university hospital in Taiwan.

C C Hung1, Y C Chen, S C Chang, K T Luh, W C Hsieh.   

Abstract

The incidence of nosocomial candidemia increased 27-fold over the past 13 years at National Taiwan University Hospital. In order to investigate its predisposing factors, clinical manifestations and prognostic determinants, a prospective observational study of nosocomial candidemia was undertaken at the hospital. From 1 May 1994 to 30 April 1995, 118 consecutive adult patients with 120 Candida spp blood isolates were analyzed. Clinical presentations included fever (100%) with a median duration of 3 days, diarrhea within 7 days of candidemia (27.9%) and macronodular skin emboli (7.6%). Laboratory studies showed worsening azotemia (35.6%), elevation of aminotransferase (28.3%), leukocytosis (27.1%) and thrombocytopenia (23.3%). Use of multiple antibiotics, retained vascular catheters and parenteral nutritional support were the three most common predisposing factors for candidemia. C. albicans was the most common isolate (50%), followed by C. tropicalis (20%), C. glabrata (14%), C. parapsilosis (9.2%). C. guilliermondii (2.5%), and C. Krusei (1.7%). C. tropicalis was more frequently the cause of candidemia in patients with leukemia and neutropenia, while C. glabrata was more commonly seen in patients receiving fluconazole prophylaxis. A severity scoring system adopted from prospective bacteremia studies proved to be highly predictive of mortality in candidemic patients. The overall case fatality rate was 70/118 (59.3%), and 51/70 (72.9%) were attributable to candidemia. In a multivariate analysis, the prognostic factors adversely influencing outcome were: higher severity scores, no removal of the catheter, persistent candidemia and lack of antifungal therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8640090

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  12 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.

Authors:  Z Samra; M Yardeni; N Peled; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

3.  Detection of fluconazole-resistant Candida strains by a disc diffusion screening test.

Authors:  P Sandven
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  A global theme issue: bibliography of references.

Authors:  M A Winker
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

Review 5.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.

Authors:  Pranita D Tamma; Alison E Turnbull; Anthony D Harris; Aaron M Milstone; Alice J Hsu; Sara E Cosgrove
Journal:  JAMA Pediatr       Date:  2013-10       Impact factor: 16.193

7.  Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing.

Authors:  Chi-Yang Lin; Yee-Chun Chen; Hsiu-Jung Lo; Kuo-Wei Chen; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

8.  Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.

Authors:  P Sandven; L Bevanger; A Digranes; P Gaustad; H H Haukland; M Steinbakk
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

9.  A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.

Authors:  Su-Pen Yang; Yin-Yin Chen; Han-Shui Hsu; Fu-Der Wang; Liang-yu Chen; Chang-Phone Fung
Journal:  BMC Infect Dis       Date:  2013-01-09       Impact factor: 3.090

10.  The use of Chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates.

Authors:  Hsiung-Fei Chien; Chueh-Pin Chen; Yee-Chun Chen; Po-Han Chang; Tsuimin Tsai; Chin-Tin Chen
Journal:  Int J Mol Sci       Date:  2013-04-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.